Aurie announced that the Aurie Reusable No-Touch Intermittent Catheter System™ has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) through the Class II De Novo ...

Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth ...

Hospital records unmatched growth in advanced electrophysiology procedures with 100 high-complexity atrial fibrillation ...

BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the outcome of its Pre-Submission ...

Cash Position -- $119.3 million in cash and cash equivalents as of March 31, 2025, compared to $34.9 million a year earlier; ...

The first time the company’s MAGiC catheter was used in the U.S., it did not ease into things gently. On April 22, 2026, ...

A continuous quality improvement approach helped identify and intervene in vascular access issues for patients on home ...

Add Outdoor Life (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases ...

Proton-based cardiac radioablation may offer a less invasive treatment for patients with hard-to-treat ventricular ...

An unsecured business line of credit provides flexible funding for companies without requiring collateral, but interest rates might be higher, and maximums might be lower ...